Abstract:
BACKGROUND:Genomics research is becoming increasingly globally connected and collaborative, contesting traditional ethical and legal boundaries between global and local research practice. As well, global data-driven genomics research holds great promise for health discoveries. Yet, paradoxically, current research ethics review systems around the world challenge potential improvements in human health from such research and thus undermine respect for research participants. Case reports illustrate that the current system is costly, fragmented, inefficient, inadequate, and inconsistent. There is an urgent need to improve the governance system of ethics review to enable secure and seamless genomic and clinical data sharing across jurisdictions. DISCUSSION:Building on the international privacy 'safe harbor' model that was developed following the adoption of the European Privacy Directive, we propose an international infrastructure. The goal is to create a streamlined and harmonized ethics governance system for international, data-driven genomics research projects. The proposed 'Safe Harbor Framework for International Ethics Equivalency' would consist in part of an agency supporting an International Federation for Ethics Review (IFER), formed by a voluntary agreement among countries, granting agencies, philanthropies, institutions, and healthcare, patient advocacy, and research organizations. IFER would be both a central ethics review body and also a forum for review and follow-up of policies concerning ethics norms for international genomics research projects. It would be built on five principle elements: (1) registration; (2) compliance review; (3) recognition; (4) monitoring and enforcement; and (5) public participation. SUMMARY:A Safe Harbor Framework for International Ethics Equivalency would create many benefits for researchers, countries, and the general public, and may eventually have application beyond genomics to other areas of biomedical research that increasingly engage in secondary use of data and present only negligible risks. Among the benefits, research participants and patients would have uniform adequate protection, while researchers would be ensured expert ethics review with a reduction in cost, time, administrative hassle, and redundant regulatory hurdles. Most importantly, society would enjoy the maximization of the potential benefits of genomics research.
journal_name
Genome Medjournal_title
Genome medicineauthors
Dove ES,Knoppers BM,Zawati MHdoi
10.1186/gm503subject
Has Abstractpub_date
2013-11-22 00:00:00pages
99issue
11issn
1756-994Xpii
gm503journal_volume
5pub_type
杂志文章相关文献
Genome Medicine文献大全abstract::With exome sequencing becoming a tool for mutation detection in routine diagnostics there is an increasing need for platform-independent methods of quality control. We present a genotype-weighted metric that allows comparison of all the variant calls of an exome to a high-quality reference dataset of an ethnically mat...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm473
更新日期:2013-07-31 00:00:00
abstract::Accurate interpretation of gene testing is a key component in customizing patient therapy. Where confirming evidence for a gene variant is lacking, computational prediction may be employed. A standardized framework, however, does not yet exist for quantitative evaluation of disease association for uncertain or novel g...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm347
更新日期:2012-05-28 00:00:00
abstract:BACKGROUND:Metabolomics, the non-targeted interrogation of small molecules in a biological sample, is an ideal technology for identifying diagnostic biomarkers. Current tissue extraction protocols involve sample destruction, precluding additional uses of the tissue. This is particularly problematic for high value sampl...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm332
更新日期:2012-04-30 00:00:00
abstract::Technological advances over the past several years have dramatically reduced the cost of whole-genome sequencing. At the same time, understanding of the functional significance of genetic variation has advanced considerably. The routine generation of whole-genome sequence data for individual patients will soon be suff...
journal_title:Genome medicine
pub_type: 社论
doi:10.1186/gm48
更新日期:2009-05-08 00:00:00
abstract::Osteoporosis, the most common type of bone disease worldwide, is clinically characterized by low bone mineral density (BMD) and increased susceptibility to fracture. Multiple genetic and environmental factors and gene-environment interactions have been implicated in its pathogenesis. Osteoporosis has strong genetic de...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/gm448
更新日期:2013-05-29 00:00:00
abstract:BACKGROUND:Tuberous sclerosis complex (TSC) is a genetic disease characterized by benign tumor growths in multiple organs and neurological symptoms induced by mTOR hyperfunction. Because the molecular pathology is highly complex and the etiology poorly understood, we employed a defined human neuronal model with a singl...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-016-0347-3
更新日期:2016-09-21 00:00:00
abstract::The zebrafish model is rapidly gaining prominence in the study of development, hematopoiesis, and disease. The zebrafish provides distinct advantages over other vertebrate models during early embryonic development by producing transparent, externally fertilized embryos. Embryonic zebrafish are easily visualized and ma...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm299
更新日期:2011-12-29 00:00:00
abstract::Regenerative medicine has a three-body problem: alignment of the dynamics of the genome, stem cell and patient. Focusing on the rare inherited fragile skin disorder epidermolysis bullosa, three recent innovative studies have used induced pluripotent stem cells and gene correction, revertant mosaicism or genome editing...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-015-0141-7
更新日期:2015-02-20 00:00:00
abstract:BACKGROUND:Wnt signaling is an evolutionarily conserved developmental pathway that is frequently hyperactivated in cancer. While multiple protein-coding genes regulated by Wnt signaling are known, the functional lncRNAs regulated by Wnt signaling have not been systematically characterized. METHODS:We comprehensively m...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00788-5
更新日期:2020-10-22 00:00:00
abstract::Metabolomic analysis will provide the next large set of clues to further our understanding of human health and disease. A recent study has elucidated the significant differences in the metabolomes of adipocytes, serum and an adipocyte cell line after activation of two nuclear receptors, peroxisome proliferator activat...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm270
更新日期:2011-08-23 00:00:00
abstract::Infections encountered in the cancer setting may arise from intensive cancer treatments or may result from the cancer itself, leading to risk of infections through immune compromise, disruption of anatomic barriers, and exposure to nosocomial (hospital-acquired) pathogens. Consequently, cancer-related infections are u...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/s13073-016-0306-z
更新日期:2016-04-18 00:00:00
abstract:BACKGROUND:Young age at portoenterostomy has been linked to improved outcome in biliary atresia, but pre-existing biological factors may influence the rate of disease progression. In this study, we aimed to determine whether molecular profiling of the liver identifies stages of disease at diagnosis. METHODS:We examine...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm154
更新日期:2010-05-13 00:00:00
abstract::The analysis of the genomic distribution of viral vector genomic integration sites is a key step in hematopoietic stem cell-based gene therapy applications, allowing to assess both the safety and the efficacy of the treatment and to study the basic aspects of hematopoiesis and stem cell biology. Identifying vector int...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-014-0067-5
更新日期:2014-09-03 00:00:00
abstract:BACKGROUND:Clinical laboratory (lab) tests are used in clinical practice to diagnose, treat, and monitor disease conditions. Test results are stored in electronic health records (EHRs), and a growing number of EHRs are linked to patient DNA, offering unprecedented opportunities to query relationships between genetic ri...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00820-8
更新日期:2021-01-13 00:00:00
abstract::There are still many open questions in data-analytic research pertaining to biomarker development in the era of personalized/precision medicine and big data. Among them is the question of what constitutes best practice for the extraction of prioritized lists of candidate biomarkers from smaller studies that are 'hypot...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm507
更新日期:2013-11-29 00:00:00
abstract::Genome-wide association studies have shown unequivocally that common complex disorders have a polygenic genetic architecture and have enabled researchers to identify genetic variants associated with diseases. These variants can be combined into a polygenic risk score that captures part of an individual's susceptibilit...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/s13073-020-00742-5
更新日期:2020-05-18 00:00:00
abstract:BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm385
更新日期:2012-11-12 00:00:00
abstract::Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tumor-specific T cell recognition. Recently, researchers and clinicians have leveraged next generation sequencing technologies to identify neoantigens and to create personalized immunotherapies for cancer treatment. To cr...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/s13073-019-0666-2
更新日期:2019-08-28 00:00:00
abstract::Pancreatic cancer is a highly lethal tumor type for which there are few viable therapeutic options. It is also caused by the accumulation of mutations in a variety of genes. These genetic alterations can be grouped into those that accumulate during pancreatic intraepithelial neoplasia (precursor lesions) and thus are ...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/gm430
更新日期:2013-03-28 00:00:00
abstract::To help overcome the bottlenecks that limit the development of diagnostic and therapeutic products, academic and industrial researchers, patient organizations and charities, and regulatory and funding institutions should redefine the basis for sharing the knowledge collected in large-scale clinical and experimental st...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm29
更新日期:2009-03-04 00:00:00
abstract::The anticonvulsant carbamazepine has a high incidence of cutaneous adverse drug reactions. A recent prospective clinical trial in Taiwan has indicated that HLA-B*1502 screening will reduce the incidence of life-threatening adverse reactions to carbamazepine, while a genome-wide association study has identified the HLA...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm243
更新日期:2011-05-30 00:00:00
abstract::Whole genome sequencing is increasingly used to study phenotypic variation among infectious pathogens and to evaluate their relative transmissibility, virulence, and immunogenicity. To date, relatively little has been published on how and how many pathogen strains should be selected for studies associating phenotype a...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-014-0101-7
更新日期:2014-11-15 00:00:00
abstract:BACKGROUND:Recent highly publicized cases of premature patient assignment into clinical trials, resulting from non-reproducible omics analyses, have prompted many to call for a more thorough examination of translational omics and highlighted the critical need for transparency and reproducibility to ensure patient safet...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-015-0202-y
更新日期:2015-07-25 00:00:00
abstract:BACKGROUND:Abnormal pre-mRNA splicing regulation is common in cancer, but the effects of chemotherapy on this process remain unclear. METHODS:To evaluate the effect of chemotherapy on slicing regulation, we performed meta-analyses of previously published transcriptomic, proteomic, phosphoproteomic, and secretome datas...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-018-0557-y
更新日期:2018-06-27 00:00:00
abstract:BACKGROUND:Studies of cancer mutations have typically focused on identifying cancer driving mutations that confer growth advantage to cancer cells. However, cancer genomes accumulate a large number of passenger somatic mutations resulting from various endogenous and exogenous causes, including normal DNA damage and rep...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00745-2
更新日期:2020-05-29 00:00:00
abstract:UNLABELLED:Bibliographic records in the PubMed database of biomedical literature are annotated with Medical Subject Headings (MeSH) by curators, which summarize the content of the articles. Two recent publications explain how to generate profiles of MeSH terms for a set of bibliographic records and to use them to defin...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm382
更新日期:2012-10-30 00:00:00
abstract::Immunoinformatics involves the application of computational methods to immunological problems. Prediction of B- and T-cell epitopes has long been the focus of immunoinformatics, given the potential translational implications, and many tools have been developed. With the advent of next-generation sequencing (NGS) metho...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/s13073-015-0245-0
更新日期:2015-11-20 00:00:00
abstract::A report on the 62nd Annual Meeting of the American Society of Human Genetics, San Francisco, California, USA, 6-10 November 2012. ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm398
更新日期:2012-12-19 00:00:00
abstract::CRISPR/Cas9 has revolutionized cancer mouse models. Although loss-of-function genetics by CRISPR/Cas9 is well-established, generating gain-of-function alleles in somatic cancer models is still challenging because of the low efficiency of gene knock-in. Here we developed CRISPR-based Somatic Oncogene kNock-In for Cance...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-019-0627-9
更新日期:2019-04-16 00:00:00
abstract:BACKGROUND:Evidence for genetic contribution to complex diseases is described by recurrence risks to relatives of diseased individuals. Genome-wide association studies allow a description of the genetics of the same diseases in terms of risk loci, their effects and allele frequencies. To reconcile the two descriptions ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm131
更新日期:2010-02-02 00:00:00